Cedars-Sinai Medical Center to Expand Clinical Safety and Effectiveness Evaluation of Cardiac Cell Therapy After Winning $7.3 Million California Institute for Regenerative Medicine Grant
Cedars-SinaiResearchers from the Cedars-Sinai Heart Institute and the Cedars-Sinai Department of Medicine are expanding their ongoing evaluation of a novel cell-based therapeutic candidate into the area of pulmonary arterial hypertension (PAH). This work will be supported by a recently-awarded $7.3 million grant from the California Institute for Regenerative Medicine.